High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients – final analysis of a randomized, multicenter, phase III trial
Petzer et al. Supplementary Appendix
Petzer et al. Supplementary figure provided by the authors.